Mutual Funds

Stable performer that rides out volatility

Yoganand D | Updated on October 21, 2018 Published on October 20, 2018

The fund has been able to contain downside risks better in choppy markets

Investors with a low risk appetite can consider buying the units of UTI Equity, a multi-cap fund with a long-term track record. The fund’s performance has notably improved over the past year, after a muted show in 2015 and 2016.

Though the fund delivered a good return of 30 per cent in 2017, it underperformed the category average. That said, it has made a strong comeback this year, delivering 1.3 per cent return year-to-date, while the category average is a negative return of 8.6 per cent.

Also, while the fund may not have delivered chart-topping returns in the past, its performance has been less volatile.

In particular, it has been able to contain the downside risk better (2008 and 2011), as is evident from assessing the fund’s Sortino ratio — which measures the performance of a scheme during downtrends.

Hence, given the current volatility in the market, the fund is a good option for risk-averse investors. It has delivered steady returns of 14.2 and 16.7 per cent over seven- and 10-year time-frames, respectively, beating the benchmark returns of 12 per cent and 13.5 per cent.

Investors can choose the systematic investment plan (SIP) route to ride out the market volatility better.

Following SEBI’s categorisation and rationalisation of mutual funds, UTI Equity moved from the large- to the multi-cap category. But since the fund more or less followed a multi-cap approach (60 per cent in large-caps and rest in mid- and small-caps), there has not been a drastic change post-re-categorisation. The benchmark, though, changed from S&P BSE 100 to S&P BSE 200. UTI Bluechip Flexicap (a multi-cap fund) was also merged into UTI Equity in May 2018.

Strategy

The underperformance of the fund in 2015 and 2016 could be attributed to the lacklustre performance of the software sector, which is one of the fund’s top-preferred sectors.

However, its penchant for the sector paid off in the latter part of 2017 and in 2018, as software stocks came back in favour. This has boosted the fund’s NAV.

UTI Equity has outpaced its benchmark as well as category average by a good margin over the past year. The turnaround in the performance has pushed the fund to the top of the category.

It has beaten peers such as Reliance Multi Cap, Mirae Asset India Equity and Principal Multi Cap Growth.

UTI Equity almost fully invests in equities, and holds about 58 per cent in large-caps, 32 per cent in mid-caps and the balance in small-caps.

The top four sectors — banks, software, pharma and finance — form the majority (about 58 per cent) of the portfolio. Within the banking space, the fund holds private sector banking stocks that continue to do well, such as HDFC Bank, IndusInd Bank and Kotak Mahindra Bank.

Portfolio

While marginally trimming its allocation to the banking space over the past one year, the fund had increased its exposure to the software and industrial products sectors.

It has also gradually reduced exposure to automobiles. Healthcare services and construction sectors got added to the portfolio almost a year ago.

Barring the top 4-5 stocks, the fund takes a diffused approach and allocates less than 4 per cent to individual stocks. UTI Equity holds about 58 stocks.

It is underweight in financial, automobile and FMCG, whereas overweight in healthcare, software, services and chemicals. Bajaj Finance, HDFC Bank, IndusInd Bank, Infosys and TCS are the top holdings.

Published on October 20, 2018

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.